Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pathologic Complete Response × Vinblastine × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Pathologic Complete Response 1

Interventions

Trastuzumab 5 Carboplatin 5 Docetaxel 4 pertuzumab 3 Paclitaxel 3 Cyclophosphamide 3 pembrolizumab 2 Epirubicin 2 Doxorubicin 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 taxane 1 talazoparib 1 sarilumab 1 pyrotinib 1 pirarubicin 1 pexidartinib 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 durvalumab 1 dostarlimab 1 cemiplimab 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04781725 2021-11-17

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

Ottawa Hospital Research Institute

Phase 2 Unknown

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡